Critical

Blast crisis of chronic myeloid leukaemia

Leukaemia · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Transformation of chronic myeloid leukaemia to acute leukaemia with more than 20% blasts, causing marrow failure, leukostasis and rapid clinical deterioration.

Red flags

  • Leukostasis (breathlessness, confusion, priapism)
  • Tumour lysis syndrome
  • DIC / bleeding
  • Very high blast count

Assessment

Differential diagnosis

  • De novo acute leukaemia
  • Accelerated phase CML
  • Leukemoid reaction
  • Leukostasis (other)
  • Myelofibrosis

Investigations

  • FBC and blood film (blasts)
  • U&E, urate, LDH, phosphate, calcium (tumour lysis)
  • Coagulation / DIC screen
  • Bone marrow and cytogenetics
  • Assess for leukostasis (CNS, pulmonary)

Management

  • Assess for leukostasis, tumour lysis and DIC
  • Aggressive hydration and tumour lysis prophylaxis
  • Urgent haematology referral
  • Supportive care and transfusion as needed
  • Start disease-directed therapy per specialist
  • Consider leukapheresis for symptomatic leukostasis

Drugs & doses

IV fluids and rasburicase / allopurinol for tumour lysis
Tyrosine kinase inhibitor +/- chemotherapy (specialist)
Blood product support

Disposition

Admit; urgent haematology.

Complications & pitfalls

  • Leukostasis
  • Tumour lysis syndrome
  • DIC
  • Marrow failure

Exam pearls

  • Blast crisis may be the first presentation of previously undiagnosed CML.
  • Anticipate and prevent tumour lysis before starting therapy.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.